Comment on "Elevation of Serum Carcinoembryonic Antigen Concentration Caused by Everolimus-Induced Lung Injury: A Case Report".

Nomoto, Hiroshi; Miyoshi, Hideaki; Sekizaki, Tomonori; Atsumi, Tatsuya

Nomoto, Hiroshi; Miyoshi, Hideaki; Sekizaki, Tomonori; Atsumi, Tatsuya.

Afiliação

Nomoto H; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Miyoshi H; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Sekizaki T; Department of Diabetes and Lipid Metabolism Internal Medicine, Hokkaido Medical Center, Sapporo, Japan.
Atsumi T; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Ann Thorac Cardiovasc Surg ; 24(3): 165-166, 2018 06 20.

Article em En | MEDLINE | ID: mdl-29553086

Assuntos

Antígeno Carcinoembrionário/sangue; Everolimo; Biomarcadores Tumorais/sangue; Humanos; Lesão Pulmonar; Neoplasias Pulmonares/sangue

Palavras-chave

adverse events; carcinoembryonic antigen; everolimus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno Carcinoembrionário / Everolimo Limite: Humans Idioma: En Revista: Ann Thorac Cardiovasc Surg Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google